Mind the gap in kidney care: Translating what we know into what we do

被引:0
|
作者
Luyckx, Valerie A. [1 ,2 ,3 ]
Tuttle, Katherine R. [4 ,5 ]
Abdellatif, Dina [6 ]
Correa-Rotter, Ricardo [7 ]
Fung, Winston W. S. [8 ]
Haris, Agnes [9 ]
Hsiao, Li-Li [2 ]
Khalife, Makram [10 ]
Kumaraswami, Latha A. [11 ]
Loud, Fiona [10 ]
Raghavan, Vasundhara [10 ]
Roumeliotis, Stefanos [12 ]
Sierra, Marianella [10 ]
Ulasi, Ifeoma [13 ]
Wang, Bill [10 ]
Lui, Siu-Fai [14 ]
Liakopoulos, Vassilios [12 ]
Balducci, Alessandro [15 ]
机构
[1] Univ Zurich, Epidemiol Biostat & Prevent Inst, Dept Publ & Global Hlth, Hirschengraben 84, CH-8001 Zurich, Switzerland
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Renal Div, Boston, MA 02115 USA
[3] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa
[4] Providence Inland Northwest Hlth, Providence Med Res Ctr, 105 W 8th Ave,Suite 250 E, Spokane, WA 99204 USA
[5] Univ Washington, Dept Med, Div Nephrol, Seattle, WA USA
[6] Cairo Univ, Dept Nephrol, Pediat Hosp, Cairo, Egypt
[7] Natl Med Sci & Nutr Inst Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City, DF, Mexico
[8] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Ninth Floor,Lui Che Woo Clin Sci Bldg,32 Ngan Shi, Hong Kong, Peoples R China
[9] Peterfy Hosp, Neurol Dept, Budapest, Hungary
[10] ISN, ISN Patient Liaison Advisory Grp, Brussels, Belgium
[11] Tamilnad Kidney Res Tanker Fdn, Chennai, Tamil Nadu, India
[12] Aristotle Univ Thessaloniki, AHEPA Hosp, Sch Med, Dept Nephrol 2, Thessaloniki, Greece
[13] Univ Nigeria, Coll Med, Dept Med, Ituku Ozalla, Enugu State, Nigeria
[14] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Hlth Syst Policy & Management, Shatin, Hong Kong, Peoples R China
[15] Italian Kidney Fdn, Rome, Italy
关键词
chronic kidney disease; equity; kidney care; public health; World Kidney Day; MIDDLE-INCOME; DISEASE; CKD; MANAGEMENT; MEDICINES; BARRIERS; OUTCOMES; BURDEN; RISK;
D O I
10.1111/jorc.12495
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.
引用
收藏
页码:79 / 91
页数:13
相关论文
共 50 条
  • [31] MENSTRUALLY RELATED DISORDERS - WHAT WE DO KNOW, WHAT WE ONLY BELIEVE THAT WE KNOW, AND WHAT WE KNOW THAT WE DO NOT KNOW
    HALBREICH, U
    CRITICAL REVIEWS IN NEUROBIOLOGY, 1995, 9 (2-3): : 163 - 175
  • [32] Preeclampsia: What we know and what we do not know
    Roberts, JM
    SEMINARS IN PERINATOLOGY, 2000, 24 (01) : 24 - 28
  • [33] WHAT DO WE KNOW, AND WHAT SHOULD WE KNOW?
    Flume, Patrick A.
    PEDIATRIC PULMONOLOGY, 2009, : 144 - 145
  • [34] From what we know to what we do: translating stroke rehabilitation research into practice
    Walker, Marion F.
    Fisher, Rebecca J.
    Korner-Bitensky, Nicol
    McCluskey, Annie
    Carey, Leeanne M.
    INTERNATIONAL JOURNAL OF STROKE, 2013, 8 (01) : 11 - 17
  • [35] WHAT DO WE KNOW - WHAT SHALL WE DO - WHAT DO WE TELL
    Radstake, Timothy R.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 48 - 49
  • [36] We do not know what we do not know
    Spaeth, GL
    OPHTHALMIC SURGERY AND LASERS, 1999, 30 (05): : 337 - 340
  • [37] How Do We "Know" What We "Know?" And Change What We "Know?"
    Fosshage, James L.
    PSYCHOANALYTIC DIALOGUES, 2011, 21 (01) : 55 - 74
  • [38] Do we know what we test and do we test what we want to know?
    Klugkist, Irene
    van Wesel, Floryt
    Bullens, Jessie
    INTERNATIONAL JOURNAL OF BEHAVIORAL DEVELOPMENT, 2011, 35 (06) : 550 - 560
  • [39] Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?
    Amauri Dalla Corte
    Carolina F. M. de Souza
    Maurício Anés
    Roberto Giugliani
    Child's Nervous System, 2017, 33 : 1073 - 1080
  • [40] Hydrocephalus and mucopolysaccharidoses: what do we know and what do we not know?
    Dalla Corte, Amauri
    de Souza, Carolina F. M.
    Anes, Mauricio
    Giugliani, Roberto
    CHILDS NERVOUS SYSTEM, 2017, 33 (07) : 1073 - 1080